Curio Wellness, a cGMP-certified, vertically integrated cannabis company, has been granted the first-ever US patent for its cannabis sleep product, Good Night by Curio.
The patent, designated as Utility Patent 11,654,130, was awarded to Curio Wellness on May 23, 2023, and will remain in force until January 2042, per a press release.
Good Night, the cannabis sleep aid line available in Maryland has been leading the market since its introduction in 2021. The product, in the form of ratio tablets, is designed to help consumers fall asleep more quickly, stay asleep for longer and minimize morning grogginess.
Curio Wellness' patented technology secures a distinctive pulse-delivery system for medicinal cannabis sleep products.
"This patent validates the revolutionary nature of the product development efforts at Curio and the novel application of our pulse-release technology," said Dr. Edward Rudnic, chairman of Curio’s scientific board and its chief scientific officer.
Michael Bronfein, CEO of Curio Wellness and co-inventor, called the patent a milestone. “This patent is a significant and exciting milestone for Curio, and solidifies our commitment to developing cutting-edge cannabis products that enable our patients to enjoy a better quality of life.”
Curio Wellness, based in Maryland, is recognized as the leading developer of cannabis-derived medical products in the state.
"This is the first of many condition-specific product patents we anticipate to issue over the coming years thanks to the continued innovation and unmatched clinical testing executed by Curio’s product innovation team," Rudnic concluded.
Related News
Who Needs More Sleep? UCLA Study Shows Low-Dose CBD Is More Effective Than Melatonin
Curio Wellness Launches Two Cannabis Product Lines Focused On Gut Health And Active Lifestyles
Curio Wellness' Medical Cannabis Coming To Missouri Via New Partnership
Photo: Courtesy Of Brett Jordan On Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!